• Focal Segmental Glomerulosclerosis Market Regions, Key Players, Research - Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disease affecting the kidney's filtering system (glomeruli) and resulting in serious scarring and end stage renal disease. For instance, according to the article in Clinical Journal of American Society of Nephrology, 2017, FSGS incidence rates are often higher in men, an estimated 1.5-fold higher as compared to women. FSGS is characterized by symptoms such as edema, proteinuria, weight gain, increased cholesterol, and proteins in blood. Focal Segmental Glomerulosclerosis Market – Drivers As there is no drug approved for the treatment of FSGS yet. Thus, limited treatment therapy and government funding for research on rare diseases are expected to drive growth of the FSGS market. For instance, in 2015, the U.S. Food and Drug Administration (FDA) and European Commission both granted Sparsentan, as orphan drug designation for the treatment of FSGS. This Sparsentan is a novel drug candidate with dual mechanism of action combines angiotensin receptor blockade with endothelin receptor blockade and is currently being evaluated in a Phase III trial, which expected to complete in December 2022. For instance, Pfizer Inc., is undergoing clinical trial for the evaluation of its drug, PF-06730512 in adults with primary focal segmental glomerulosclerosis. This drug is currently in Phase II study and is expected to complete in June 2021. Moreover, government investments into the rare disease treatment is expected to drive the growth of market. For instance, according to an annual data report from the U.S. Renal Data System 2017, Medicare invested around US$ 34 billion for people on dialysis with chronic kidney disease. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2224 Focal Segmental Glomerulosclerosis Market – Taxonomy By Disease Type Primary Focal Segmental Glomerulosclerosis,Secondary Focal Segmental Glomerulosclerosis By Drug Sparsentan (Phase III) By Distribution channels Hospital Pharmacies,Retail Pharmacies,Online Pharmacies Focal Segmental Glomerulosclerosis Market – Restraint Lack of awareness among population regarding this disease and high cost of dialysis therapy may restrict growth of this market to some extent. For instance, according to an article published in University of Michigan 2017, awareness among patients with FSGS is considerably low when the patients are in primary stage of FSGS, which is hampering growth of the FSGS market. Focal Segmental Glomerulosclerosis Market – Regional Analysis On the basis of region, the global focal segmental glomerulosclerosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the FSGS market due to high prevalence of FSGS along with chronic kidney diseases. For instance, According to an annual data report by the U.S. Renal Data System 2017, the overall burden of kidney disease, kidney failure with dialysis, and kidney transplantation is highest in U.S., thus driving the growth of the focal segmental glomerulosclerosis market. Asia Pacific region is expected to witness significant growth in market due to collaboration agreements and partnerships among various players. For instance, Oraxion Therapeutics, Inc., a subsidiary of Indian company Aten Porus, is undergoing preclinical and efficacy study of the drug, ORX-301, which can be used in the treatment of FSGS. In February 2018, Oraxion Therapeutics, Inc., entered into an Option Agreement with the U.S-based Biopharmaceutical Company and under this agreement, U.S. based company gets exclusive rights for further clinical studies and license of this drug in the U.S. The key players operating in the focal segmental glomerulosclerosis (FSGS) market include GlaxoSmithKline plc., Novartis AG, Variant Pharmaceuticals, Inc., ChemoCentryx, Inc., Retrophin, Inc., AbbVie, Inc., Pfizer, Inc., AstraZeneca plc., Sanofi S.A, and Teva Pharmaceutical Industries Ltd. Click To Reading More On Focal Segmental Glomerulosclerosis Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Have the Real Housewives of Cheshire Opted for Plastic Surgery? - If you have not watched the Real Housewives of Cheshire, you probably do not know the answer to this question. All things aside, you might be considering having a procedure such as Upper Eyelift Manchester done as well. No matter how you look at it, TV stars have an amazing appearance. At first, you might not even think to ask yourself if they have had any work done. In reality, most of them have. The truth is that the pressure of having an amazing body is pretty high, especially when you are on a TV show. Of course, this does not mean that you can’t have the right kind of procedure done, if you wanted to. Now, when it comes to the Real Housewives of Cheshire, you should know that yes, they have opted for the help of the right surgeon. One of the ladies felt that her breast area needed some work, which is why she opted for a boob job. The other one decided that a Mummy Makeover, which is also known as a combination of two different procedures: breast job and a tummy tuck. After you have had children, you realize that your breasts and the skin on your tummy are no longer the same. The muscles on your tummy are loose and there is just so much skin that you are certain you will not be able to get rid of it even if you go to the gym 7 days a week. This is just something that happens due to pregnancy. The belly grows a lot in a really short time and the skin does not have time to adjust to the new size. Before you know it, the little miracle is born and the skin is soft, loose and you have stretch marks all over. Another problem in this case would be the belly fat that seems to be too stubborn to go away, no matter how many diets you follow and how much you exercise on a regular basis. After giving birth, getting back to your old self is nearly impossible without a bit of help from the right plastic surgeon. The good news is that the right professional will handle this entire situation in a matter of hours. Yes, you will need a bit of time to heal, but after the swelling and bruising go away, you will look and feel amazing. It will take a few weeks, but it will be worth it. If you have noticed that the skin on your upper lid seems to have a heavy appearance, it might be a good idea to consider Upper Eyelift Manchester. This is the kind of procedure that will help you long younger and will give you just that confidence boost that you needed. Even if you are well in your 50s, this kind of surgery will erase years off of your face. Take the time to make an appointment to see the right plastic surgeon and talk about your option. Despite the fact that you might have already decided you wanted one of these procedures, you should know that there are a few important matters that need to be discussed first. For example, if you smoke, vape or are overweight, the surgeon will not agree to take you on as a patient. Also, there are all sorts of questions that you might not have thought about, but that you will find the answer to when you meet the doctor for the first time. The right specialists will tell you everything you need to know about the procedure and will make sure that your expectations are realistic. You can even see what you will look like after the procedure in the doctor’s office, before you are even scheduled for surgery as you will be shown a virtual result. If you would like to opt for any plastic procedure, you should consider doing some research first. It would be useful to find out more about the exact kind of surgery you are interested in so that you can make a list of all the questions you would like to ask the surgeon. This can happen at your first appointment. Depending on his answers, it will be easier for you to make a decision. It is pretty obvious that the Real Housewives of Cheshire ( https://reflectclinic.co.uk/real-housewives-of-cheshire ) have invested in plastic surgery. If you are interested in the kind of work that you can have done, learn more about Upper Eyelift Manchester ( https://reflectclinic.co.uk/upper_eyelift ) and other procedures by visiting our website! (Added: Fri Jan 18 2019 Hits: 71 Rating: 0.00 Votes: 0) Rate It

• Depression - You are depressed because you bother. You bother because you care. You care because you are a good person. And because you are a good person, depression is one of your hurdle in being right. Nothing good come easy. Why can’t you think this way? Half the burden is gone, the moment you stop beating and being too harsh on yourself. Depression as a disorder and disease can occur owing different reasons. The environment and psychology play their respective roles in making you depressed alongside genetics and biology and other external and internal factors (of mind). The actual cause is still unknown. It is an outcome of complexities. Typically depression is characterized by persistent sadness, a feeling of low self-esteem, loss of interest and abjection. Women are gripped more than men and is very common globally. Am I depressed? Perhaps this question one should ask oneself if he/she doubts whether or not he/she is depressed. Generally, a feeling of sadness or lack of interest to certain things, a down state of mind and the like are not very uncommon in our daily lives, and they are part and parcel of the same. But if these continue to immure your existence, retracting you from the joys of living, then there is a problem. Everything Health If I am, how do I overcome? Depression often produces a feeling of helplessness. Maybe you have taken medical help and are consuming medicines (clinical depression), despite there are natural ways you can follow to add to the recovery even faster. Here’s how- 1. Come out of the toxic spot- It is often the case that the cause of your depression is kindled by some person or event that you are still clinging to or in some way or the other is associated with your heartbreak. Find a bypass. 2. Get a purpose in life- Life is much more than dwelling on something terrible that happened. The past is past, and it has no power in your present. Find something that you love effortlessly and chase the same. Find your purpose in life. 3. Take on spirituality- Where science ends, spiritual beings. Read the sayings of saints and sages for they have pondered life into particles. Maybe you find a way out. 4. Systematize life- Enough of your swimming upstream in the river of life. Come into the flow. Stop defying nature. Live life systematically. Wake up, eat and sleep following within a schedule. 5. Support your body in recovery- While you are seeking to come past depression, it is highly essential that you support your body in doing so. Exercise regularly, drink enough water and consume seasonal fruits and vegetable. (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Genetic Testing Services Market: Rise in the Adoption of Genetic Services to Drive the Demand - The global genetic testing services market is expanding with the increasing incidence of cancer and rare as well as autoimmune diseases. The global genetic testing services market was valued at US$ 33,500.0 Mn in 2016 and is projected to register a compounded annual growth rate (CAGR) of over 7.6% from 2017 to 2025, to reach value of US$ 64,131.0 Mn by 2025. The global market is witnessing relatively high growth, owing to increase in awareness among people, adoption of genetic testing by physicians and patients, and rise in the prevalence of chronic diseases across the globe. Read Report Overview: https://www.transparencymarketresearch.com/genetic-testing-services-market.html Genetic test is a type of medical test which analyzes the changes in chromosomes, proteins, or genes, which may be caused by any suspected genetic condition or disease. Genetic testing is also performed on tumors to diagnose cancer and plan the treatment. Several genetic tests are used currently. The key types of genetic testing are newborn screening, prenatal testing, pre-implantation testing, carrier testing, etc. Several methods such as molecular method, chromosomal method, and biochemical method can be used for genetic testing. Genetic testing is employed to identify the risk factors, to screen the newborns, and also in forensics. The global genetic testing services market is witnessing significant growth and is expected to expand at a robust CAGR during the forecast period. Rise in the adoption of health care IT solutions for genetic testing, increase in the prevalence of cancer and cardiovascular diseases, and benefits offered by genetic testing (such as specificity and early identification) are expected to have a positive impact on the global genetic testing services market during the forecast period. Furthermore, rising awareness about genetic services and increasing incidence of common autoimmune diseases are likely to propel the global genetic testing services market during the forecast period. Lack of awareness about genetic services in several developing regions and high cost of genetic tests in several countries are a few of the factors restricting the global genetic testing services market. The global genetic testing services market has been segmented based on test type, service provider, application, and geography. Based on test type, the market has been segmented into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing, and others. Among these, the predictive & presymptomatic testing segment held a major market share, in terms of revenue, in 2016. Increase in awareness about diseases such as cancer and early detection of diseases are some of the factors fueling the segment. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10235 Based on service provider, the global genetic testing services market has been classified into hospital-based laboratories, diagnostics laboratories, specialty clinics, and others. The hospital-based laboratories segment held the largest share of the market in 2016, in terms of revenue, followed by the diagnostic laboratories segment. User convenience and increasing number of hospitals are a few factors projected to propel the hospital-based laboratories segment during the forecast period. Based on application, the global genetic testing services market has been divided into oncology, infectious diseases, autoimmune diseases, and others. The oncology segment is anticipated to dominate the market during the forecast period, due to high prevalence of cancer across the world. Geographically, North America dominates the global genetic testing services market, followed by Europe. Developed countries such the U.K., the U.S., and Germany witness more awareness about genetic testing. Furthermore, developed infrastructure, increase in health care investments, and robust R&D activities in these countries are driving the market in these countries. The market in the Asia Pacific region is expanding rapidly. Developed countries in the region such as Australia and Japan are offering growth opportunities to the genetic testing services market. India and China are potential markets for genetic services, due to increase in the prevalence of infectious diseases in these countries. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10235 Some of the key players operating in the global genetic testing services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Hoffmann-La Roche Ltd, Illumina, Inc., CENTOGENE AG, and 23andMe, Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Tumor Ablation Market - Rising Case of Liver Cancer to Augment Growth - The market is anticipated to exhibit an exponential growth in the years to come. Rapid adoption of new type of treatment to fight cancer with better efficiency of tumor ablation against traditional therapies is favoring the tumor ablation market. Apart from this, increasing public awareness programs in order to detect cancer at a very first step along with funds provided by government of various countries for cancer research, particularly in developed countries is stoking the tumor ablation market. Read Report Overview: https://www.transparencymarketresearch.com/tumor-ablation-market.html However, it has been noticed that the exorbitant cost of tumor ablation techniques coupled with constraint subsidy scenarios is deterring the growth of the global tumor ablation market. The global tumor ablation market is classified on the basis of disease indication, technology, geography, and end user. On the basis of technology, the market is segregated into high-intensity focused ultrasound, radiofrequency ablation, microwave ablation, laser interstitial thermal, cryoablation, and others. Amongst them microwave ablation is the most popularized technology among the healthcare sector. Minimal side effects and less duration of therapy has made microwave ablation more favored technology. Cryoablation technology is the second most used technology after cryoablation. However, it has been noticed radiofrequency ablation technology is at present leading the market owing to the prolonged rise in liver cancer cases among population all over the world. Radiofrequency ablation technology held a whopping 35.6% of the market share in recent years. On the basis of disease the, the global tumor ablation market is bifurcated into lung cancer, kidney cancer, breast cancer, bone cancer, prostate cancer, liver cancer, and others. Out of these, case of lung cancer is likely to grow at a staggering rate owing to rise in pollution and cigarette smoking level. It is predicted that this segment is likely to be valued at US$373.7mn by the end of the forecasts period. However, on the flip side, liver cancer registered 23.8% share in the overall market. According to WHO, in 2012, liver cancer became the primary reason of death for 745000 individual worldwide. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18656 On the basis of end user, the global tumor ablation market can be split into cancer specialty clinics, hospitals, and others. Hospitals is known to record the highest number of footfalls owing to rising practices of visiting hospitals for well-being, coupled with presence of advanced facilities in hospitals. On the other hand, cancer specialty clinics is expected to beat hospitals on the base of growth rate due to rising preference towards cancer specialty clinics. On the basis of geography, the market is segregated into Asia Pacific, Middle East and Africa, Latin America, Europe, and North America. Contribution by the U.S made North America to hold a staggering 34% of share in the overall market in recent years. Advanced healthcare facilities along with substantial awareness regarding the upcoming technologies for cancer has helped the market to grow in the region. However, in coming years, Asia Pacific due to rapid urbanization, expansion of healthcare facilities, accompanied with rising disposable income is likely to provide better opportunities to the players in the market. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18656 Some of the major players in the market are BVM Medical Limited, Sonacare Medical LLC, BTG Internation LET., and Medtronic plc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 18 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Antivenom Market | Share | Analysis 2018 -2024 - Antivenom Market | Share | Analysis 2018 -2024 An In-Depth Research And Development On Global Antivenom Market Changing aspects of antivenom market Factors which are responsible for the growth of the antivenom market include- • Increase death numbers due to venomous bites • Increased incidences of the venomous bites in underdeveloped countries and their regions • Upcoming government initiatives to develop antivenoms and their development from the manufacturers. However, intricacy in regulatory policies, lack of funding in antivenom development, and high cost of the product are impeding the growth of antivenom market. Request Sample Report : https://bit.ly/2D45kPL Regional analysis: North America holds the largest share in the market due to presence of snake poison control centers, approval of antivenom products, presence of great quality healthcare facilities and increase in clinical trial rounds. Asia Pacific anti venom market is growing at a lucrative market growth due to rising number of snake bite cases when compared to urbanized regions. While in Africa and Asia-Pacific regions have a growing demand for antivenom. According to WHO statistics, about 5million snake bites occurs in a year with half resulting into serious complication such as permanent disabilities and amputations, and death. Market summary: Market players are actively involved in R & D to develop antivenoms to meet the demand of the market. With newer and better antivenoms in the market, there will be steady growth. For e.g. Instituto Bioclon S.A developed Equine F(ab’)2 (clinical trials phase2) in antivenin to treat poison from scorpion sting. With increasing demand for specific antivenom for different species of snakes, the market growth is inevitable. The local market players are focused on the increasing their production for antivenom such as Bharath Serum Vaccines limited and Vins Bioproducts in Asia-Pacific region. While the Middle East & African regions, South Africa will have lucrative business opportunity due to highest number of snakes in the country. Some of the key market players from Antivenom market are- • Vins Bioproducts Limited (India) • Bharat Serum and Vaccines Limited (India) • CSL Limited (Victoria) • Rare Disease Therapeutics, Inc. (U.S.) • F. Hoffmann-La Roche AG (Switzerland), • Instituto Bioclon • S.A. de C.V.(Mexico) • Incepta Vaccine Ltd. (Bangladesh) • BTG Plc (U.K) • Merck & Co., Inc. (U.S) • Pfizer Inc. (U.S.) Notable market development: Incepta Pharmaceuticals Limited launched their first antivenom which was made locally in 2015. The global antivenom market is divided into following categories- By product type • Monovalent • Polyvalent By animal • Snake • Scorpions • Spiders • Others By end-users • Hospital Pharmacies • Retail Pharmacies • Others By geographical regions • North America • Latin America • Europe • The Middle East & Africa • Asia-Pacific For More Information: https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/ (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• "Activity Challenge App": Stay Fit, Earn Money - Numerous mobile applications are cropping up of late for every activity in life. The moment you wake up to the time you sleep everything is made easy with numerous mobile applications being developed every minute. From grooming you up to providing recipes, health consultations, weather reports, providing home needs to your doorstep, providing food, counting your steps, measuring your heart beat...and what not. And as humans we are greedy...sounding rude? But it is true. We are selfish in whatever we do. What if I do this, What if I do that? What am I going to gain from this? How would I benefit if I do this? Many businesses are cashing on this selfishness of human beings by adding monitory benefits in every transaction they do on their mobile applications. They provide cash backs, reward points, discounts and what not. Among such apps are the apps which monitor our physical fitness and also a few which motivate us to stay fit. What if someone pays you for working out? What if someone pays you for winning a small fun physical challenge? Wouldn't it be great? Of course, it would be great to have someone who does that. We shall now discuss one such mobile application which is called 'Activity Challenge'. This is for those of us who are lazy to work out and needs immense motivation to even wake up early and have a short walk. Activity challenge is one such app which enables you to meet numerous other people like you. Yes, you read it right! You are not only the one who is lazy in this world or who needs the motivation to start a fitness routine. Activity Challenge enables all such people to register with it so that you can interact with each other over a chat through the app and get to know your limitations and assets. You can find a suitable competitor for you to challenge. Such chats enable you to get motivated and to motivate others on participating in exciting physical activities ranging from simple walking to adventurous hiking. Going to the gym or doing regular exercise you know would help you stay fit but what if you would be able to earn some money while you do these activities. Yes, exactly that is what happens if you enroll with this Best Health and Fitness app. You just have to register in this by paying a dollar, which would immediately be refunded into your wallet once your account details are verified. And that's it, you can start challenging other people who registered in this app, or challenge yourself paying, say around 5$. You pay 5$, your competitor pays 5$ and then you start your challenges. May it be daily, weekly, or long-term challenges, you can challenge how much ever amount you want and on winning you would get double that amount. Isn't it exciting? The Activity Challenge app provides 56 different physical activities like simple pushups, pentathlons, Triathlons, Biathlons, Equestrian to the exciting Ice climbing, Ski jumping, Ice Hockey, etc. Not just these, you will even find some fun activities like dancing, Ice Dancing, Zumba, Gymnastics etc. Also, you can indulge in group challenges like Soccer and Basket Ball too. You just have to download the app and register to see all the exciting stuff that it has to offer. The 'Activity Challenge' app is available both in the Play Store and App Store for both the Android and iOS users. To know more details about the functionality of the app visit the website www.activity-challenge.com. (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• "Activity Challenge App": Stay Fit, Earn Money - Numerous mobile applications are cropping up of late for every activity in life. The moment you wake up to the time you sleep everything is made easy with numerous mobile applications being developed every minute. From grooming you up to providing recipes, health consultations, weather reports, providing home needs to your doorstep, providing food, counting your steps, measuring your heart beat...and what not. And as humans we are greedy...sounding rude? But it is true. We are selfish in whatever we do. What if I do this, What if I do that? What am I going to gain from this? How would I benefit if I do this? Many businesses are cashing on this selfishness of human beings by adding monitory benefits in every transaction they do on their mobile applications. They provide cash backs, reward points, discounts and what not. Among such apps are the apps which monitor our physical fitness and also a few which motivate us to stay fit. What if someone pays you for working out? What if someone pays you for winning a small fun physical challenge? Wouldn't it be great? Of course, it would be great to have someone who does that. We shall now discuss one such mobile application which is called 'Activity Challenge'. This is for those of us who are lazy to work out and needs immense motivation to even wake up early and have a short walk. Activity challenge is one such app which enables you to meet numerous other people like you. Yes, you read it right! You are not only the one who is lazy in this world or who needs the motivation to start a fitness routine. Activity Challenge enables all such people to register with it so that you can interact with each other over a chat through the app and get to know your limitations and assets. You can find a suitable competitor for you to challenge. Such chats enable you to get motivated and to motivate others on participating in exciting physical activities ranging from simple walking to adventurous hiking. Going to the gym or doing regular exercise you know would help you stay fit but what if you would be able to earn some money while you do these activities. Yes, exactly that is what happens if you enroll with this Best Health and Fitness app. You just have to register in this by paying a dollar, which would immediately be refunded into your wallet once your account details are verified. And that's it, you can start challenging other people who registered in this app, or challenge yourself paying, say around 5$. You pay 5$, your competitor pays 5$ and then you start your challenges. May it be daily, weekly, or long-term challenges, you can challenge how much ever amount you want and on winning you would get double that amount. Isn't it exciting? The Activity Challenge app provides 56 different physical activities like simple pushups, pentathlons, Triathlons, Biathlons, Equestrian to the exciting Ice climbing, Ski jumping, Ice Hockey, etc. Not just these, you will even find some fun activities like dancing, Ice Dancing, Zumba, Gymnastics etc. Also, you can indulge in group challenges like Soccer and Basket Ball too. You just have to download the app and register to see all the exciting stuff that it has to offer. The 'Activity Challenge' app is available both in the Play Store and App Store for both the Android and iOS users. To know more details about the functionality of the app visit the website www.activity-challenge.com. (Added: Fri Jan 18 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• 4th International Conference on Clinical and Counseling Psychology - Clinical and Counseling Psychology can be well said as a practice of clinical knowledge, evidence based research and scientific system to recognize, prevent advice, guide and treat the human condition to improve the pain of individuals with stressors, psychological and psychiatric disorders through psychotherapy. With the successful journey of Clinical Psychologists 2018 in different part of the world, Conference Series llc LTD conferences planned to continue its 4th International conference on Clinical and Counseling Psychology conference series saga in Tokyo, Japan from August 12-13, 2019. On this auspicious occasion, Conference Series llc LTD inviting the participants from all over the globe to take part in the 4th International conference on Clinical and Counseling Psychology at Tokyo, Japan during August 12-13, 2019. The theme of the conference highlights the “Scoping out Novel Innovations & Methodologies in Psychological Field ". Scientific Tracks designed for this conference will enable the attendees and participants to learn extremes. Importance & Scope: Clinical and Counseling Psychologists support people from all the difficulties to overcome depression, anger, anxiety. They also connect people to persist with stressful situations, overcome addictions, develop their relationships with their husband, wife or parents, and break through barriers that keep people from reaching their potential. They also give psychological tests to evaluate cognitive strengths and weaknesses, personality characteristics, and more. Why to attend? Clinical Psychology Congress paves a platform to globalize the research by installing a dialogue between industries and academic organizations and knowledge transfer from research to industry and to innovate new ideas for treatment strategies. Clinical Psychologists-2019 aims in proclaim knowledge and share new ideas amongst the professionals, industrialists and students from research areas of allied fields of Clinical Psychology and Psychiatry to share their research experiences and indulge in interactive discussions and special sessions at the event. Target Audience: • Psychiatry Scientists/Research Professors • Physicists/Chemists • Junior/Senior research fellows of Psychology Field/ Clinical Psychology Field/ Nursing Science/ Health Care. • Clinical Psychology Students • Directors of Pharmaceutical companies • Clinical Pharmacists • Members of different Psychiatry associations. Meta keywords: Psychiatry Conferences, Psychology conferences, Psychiatry Conferences in Middle East, Psychiatry, Psychiatry meetings, Counseling Psychology conference, Psychiatry conventions, Psychiatry conferences in Dubai, Psychiatry conference in Tokyo Psychiatry Symposiums, Psychiatry Congress, Psychiatry workshops, Global psychiatry events, psychology seminars, International Psychiatry Meetings, Psychiatry expos, International psychology conference, Counseling Psychology conference Stress, Dementia, Post traumatic stress disorder, Positive Psychology, Psychology conference in Middle east, Psychology conferences in USA, Psychology, Psychology meetings, Psychology events, Psychology conventions, Psychology conferences in Dubai (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• "Activity Challenge App": Stay Fit, Earn Money - Numerous mobile applications are cropping up of late for every activity in life. The moment you wake up to the time you sleep everything is made easy with numerous mobile applications being developed every minute. From grooming you up to providing recipes, health consultations, weather reports, providing home needs to your doorstep, providing food, counting your steps, measuring your heart beat...and what not. And as humans we are greedy...sounding rude? But it is true. We are selfish in whatever we do. What if I do this, What if I do that? What am I going to gain from this? How would I benefit if I do this? Many businesses are cashing on this selfishness of human beings by adding monitory benefits in every transaction they do on their mobile applications. They provide cash backs, reward points, discounts and what not. Among such apps are the apps which monitor our physical fitness and also a few which motivate us to stay fit. What if someone pays you for working out? What if someone pays you for winning a small fun physical challenge? Wouldn't it be great? Of course, it would be great to have someone who does that. We shall now discuss one such mobile application which is called 'Activity Challenge'. This is for those of us who are lazy to work out and needs immense motivation to even wake up early and have a short walk. Activity challenge is one such app which enables you to meet numerous other people like you. Yes, you read it right! You are not only the one who is lazy in this world or who needs the motivation to start a fitness routine. Activity Challenge enables all such people to register with it so that you can interact with each other over a chat through the app and get to know your limitations and assets. You can find a suitable competitor for you to challenge. Such chats enable you to get motivated and to motivate others on participating in exciting physical activities ranging from simple walking to adventurous hiking. Going to the gym or doing regular exercise you know would help you stay fit but what if you would be able to earn some money while you do these activities. Yes, exactly that is what happens if you enroll with this Best Health and Fitness app. You just have to register in this by paying a dollar, which would immediately be refunded into your wallet once your account details are verified. And that's it, you can start challenging other people who registered in this app, or challenge yourself paying, say around 5$. You pay 5$, your competitor pays 5$ and then you start your challenges. May it be daily, weekly, or long-term challenges, you can challenge how much ever amount you want and on winning you would get double that amount. Isn't it exciting? The Activity Challenge app provides 56 different physical activities like simple pushups, pentathlons, Triathlons, Biathlons, Equestrian to the exciting Ice climbing, Ski jumping, Ice Hockey, etc. Not just these, you will even find some fun activities like dancing, Ice Dancing, Zumba, Gymnastics etc. Also, you can indulge in group challenges like Soccer and Basket Ball too. You just have to download the app and register to see all the exciting stuff that it has to offer. The 'Activity Challenge' app is available both in the Play Store and App Store for both the Android and iOS users. To know more details about the functionality of the app visit the website www.activity-challenge.com. (Added: Fri Jan 18 2019 Hits: 30 Rating: 0.00 Votes: 0) Rate It

• 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology - Conference series is glad to welcome all the interested participants to its 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology (Euro Cancer 2019). The conference will be organized around the theme “Advancement in Cancer Research and Prospects of New Therapeutic Strategies”. Euro Cancer 2019 is a three day event consisting of a lettered scientific program, laudable talks by the top notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available cancer therapies worldwide innovative research products which can be exhibited for further development in Oncology. This UK Cancer Congress is going to be the largest and most promising international conference that specifically focuses on the Radiation therapy by bringing all Renowned Radiation Oncologists under one roof. This is a three-day multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research. Unique Features: • Our robust on-line publicity attracts 20000 users and 60000 views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences. • The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows Accepted Abstracts will be published in PubMed, MEDLINE, Pro Quest, SCOPUS, SOCOLAR, EBSCO, CAS, Hinari, Index Copernicus, Google Scholar, SCIRUS, DOAJ indexed journals Conference Highlights: https://eurocancer.expertconferences.org/ Target Audience: Oncologists, Radiologists, Chemotherapists, Doctors, Oncology Institutes, Medical Colleges, Research faculty, Academic Scientists, Students, Cancer Diagnostics Associations and Societies, Diagnostic laboratory professionals, Business Entrepreneurs, Industry professionals, Directors/Managers/CEO, Presidents & Vice Presidents, Brand Manufacturers/ Marketers of Consumer Products, Marketing, Advertising and Promotion Agency Executives Regards, Starla Eve Program Manager, Oncology Conferences 47 Churchfield Road London, W3 6AY, UK Direct: +448000148923 E-mail: eurocancer@expertsmeetings.org (Added: Fri Jan 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Quick Service by Global Air Ambulance in Varanasi at Low-cost - January 18, 2019 - Global Air Ambulance, A company which is well reputed and well-known air ambulance provider company from hospital to the station, from station to the hospital, and from the hospital to the airport and vice versa. Global Air Ambulance is one of the most common routes to transfer the serious patients from one city to another city under the full supervision and with keen assistance with Medical Team Support. This air ambulance is a most-exclusive and well-occupied service provider all over the country and its cost is very reliable. It is always ready to shift their patients at a short span of time with all the newest medical equipment. Global Air Ambulance is one of the advanced and Hi-tech air ambulance service providers which have all types of medical assistance to transfer the serious and critical patients anytime and anywhere available. Global Air Ambulance Service in Varanasi is top ranking service provider all over the state. It is always ready to take off anytime and anywhere in India even a short notice, we provide emergency services in Varanasi as well as other cities in India. It provides quick and reliable service and is always ready with all its medical instruments at a time of need. It gives the complete bed to bed service with full security and round to round checkups by MD Doctors and Paramedics. Cost Global Air Ambulance Service from Dibrugarh compromises with the money but never compromise the quality which they provide. It is the most leading provider of charter aircraft ambulance, commercial flight and train ambulance service from Dibrugarh with ICU, PICU specialist medical team. More@ https://www.globalairambulance.in/air-ambulance-services-in-dibrugarh/ (Added: Fri Jan 18 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Peripheral Intravenous Catheter Market - The global peripheral intravenous catheter market is expected to observe steady growth in 2016, reaching beyond US$ 3.8 Bn by 2016 end. Wide adoption of catheterisation techniques in patient examination, diagnosis, and treatment is anticipated to fuel the demand for PIVC. Rising disease prevalence will play a key role in driving the market growth. North America is likely to remain the largest market; Asia Pacific is expected to emerge at the fastest rate. Soaring disease prevalence will remain a prominent factor driving the demand for catheterisation, in turn pushing the market for PIVC. Apart from its usage in drug administration, increasing adoption of peripheral intravenous catheter in body fluid collection during a patient’s physical examination, is also identified to be a key driver to market growth. Prevalence of infections and epidemics are expected to further spur the demand for catheters in hospitals, clinics, ambulatory surgical centres, home healthcare units, and other healthcare centres. In addition to constantly enhancing healthcare infrastructure, the healthcare spending of consumers is also on the rise, which will favour the market growth. Technological advancements in PIVC will particularly hold a positive impact on sales, boosting the market. Peripheral intravenous catheter is considered superior to its other counterparts, which will continue to drive adoption as a preferred option over other catheter types, eventually supporting the sales of PIVC. Moreover, there have been rising efforts toward manufacturing peripheral intravenous catheter using non-irritant, user-friendly material. Moreover, manufacturers are targeting PIVC design improvisation to eliminate the associated complications. This is projected to be a major factor positively influencing the market growth. Request Sample Report @ https://www.futuremarketinsights.com/askus/rep-gb-2558 A few qualitative and technological complications associated with material composition, design, and after-effects of PIVC are expected to continue affecting mass adoption. In addition, market growth may be restricted due to expensive prices of peripheral intravenous catheter, especially in emerging economies. Conventional PIVC sales can also witness a drop owing to certain stringent medical device regulations in some of the developing countries. By product, short peripheral intravenous catheter segment will remain dominant over integrated/closed peripheral intravenous catheter segment. Short PIVC segment is further sub-segmented into ported PIVC and non-ported PIVC. While short PIVC segment is expected to register the largest market share of over 71% in 2016, integrated/closed PIVC segment will witness significant Y-o-Y growth of 8.2%. Among the two sub-segments of short PIVC, non-ported PIVC is likely to remain dominant over ported PIVC. On the basis of technology, safety peripheral intravenous catheter will continue to gain higher traction than conventional PIVC. Based on end-user, hospitals segment is likely to generate the maximum PIVC demand. Ambulatory surgical units will also record decent demand. Peripheral intravenous catheter will register maximum revenue sales in 2016 in hospitals, accounting for over 60% market share. Ambulatory surgical units will remain the second most lucrative PIVC end-user segment. Request to View TOC @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2558 By region, North America is expected to continue the leading position with around 45% share of the entire market revenues in 2016. Europe will continue to be the second largest market for PIVC with a value of over US$ 1.0 Bn in 2016. Asia Pacific is anticipated to emerge as the fastest growing region. Compared to a 5.8% of Y-o-Y of North America, APAC will witness a stronger Y-o-Y growth in 2017 over 2016. Some of the leading players in peripheral intravenous catheter market, include Becton Dickinson and Company, B. Braun Melsungen AG, Smith Medical, C. R. Bard, Inc., Vygon Group, Terumo Corporation, and Tangent Medical. Long-term Outlook: Global peripheral intravenous catheter market is slated to reach the revenues worth US$ 5.22 Bn by 2021. (Added: Fri Jan 18 2019 Hits: 9 Rating: 0.00 Votes: 0) Rate It

• Gamma Knife Market Segments, Opportunity, Growth and Forecast By End-use Industry 2015-2025 - The global Gamma Knife market, valued at US$ 172 million in 2015, is projected to increase at over 9% CAGR through 2025, surpassing US$ 400 million in revenues. Growth will be strongest in the U.S., EU5, Japan, South Korea, China, and India. Elekta and Varian Medical Systems will remain dominant players in developed regions, whereas China-based Huiheng Medical, Inc. will consolidate its position in Asia Pacific. North America, currently the largest market for Gamma Knife, will be relegated to second spot owing to strong adoption of Gamma Knife equipment in Asia Pacific. High Success Rate Boosting Adoption among End-users Increasing preference toward non-invasive procedures has positively impacted the adoption of radiation therapy, with LINAC, Cyber Knife, and Gamma Knife gaining traction in the healthcare sector. Increasing preference for minimally-invasive surgeries, positive perception toward Gamma Knife, and high success rate are among the chief factors expected to boost adoption during the forecast period, 2015-2025. Rising per capita healthcare expenditure, emphasis on R&D, and medical tourism are also expected to support the growth of Gamma Knife market in the long run. Technological advancement that make Gamma Knife safer and more effective are also expected to increase its adoption among end-users during the forecast period. However, high cost continues to be a major challenge for widespread adoption and can limit its adoption in developing countries. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-589 Brain Metastasis will be the Largest Disease Indication Segment Gamma Knife radiation therapy is used to treat a number of disease indications, including brain metastasis, cancer, AVM, and trigeminal neuralgia. Among these, use of Gamma Knife for treating brain metastasis will account for a significant percentage of global market revenues, followed by cancer and trigeminal neuralgia. Throughout the forecast period 2015-2025, brain metastasis will remain the largest disease indication segment for Gamma Knife market. Asia Pacific will pip both North America and Europe to emerge as the largest market for Gamma Knife by 2025. Robust adoption of Gamma Knife equipment in Japan, South Korea, China, and India will continue to drive the growth of the market in Asia Pacific. The Asia Pacific Gamma Knife market is projected to at over 10% CAGR during the forecast period 2015-2025. North America and Europe will lose market share to Asia Pacific and collectively account for nearly 50% revenue share of the market by 2025. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-589 Elekta, Varian Medical Systems, and Huiheng Medical, Inc. – leading Gamma Knife equipment manufacturers, will continue to leverage its position through innovative product development and foray into new markets. (Added: Fri Jan 18 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• International Conference on Frontiers in Lung Cancer - Conference Series LLC Ltd is esteemed to invite you to join the International conference on Lungs Cancer which will be held from May 06-07, 2019 at Tokyo, Japan which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions, with the special focus on the theme Prodigious Discoveries in Lung Cancer. (Added: Fri Jan 18 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Cleanroom Consumables Market Demand for Modular Cleanroom Systems to Drive Market - Cleanrooms are controlled environments with low levels of pollutants such as dust, microorganisms, and chemical vapors. Cleanrooms are used in a number of industrial processes, where pollutants can interfere and deteriorate the quality of production. However, complex and varied cleanroom regulations and increase in raw material prices are projected to hamper the growth of the global cleanroom consumables market in the near future. Read Report Overview: https://www.transparencymarketresearch.com/cleanroom-consumables-market.html The global cleanroom consumables market was valued at US$ 9,000 Mn in 2017 and is anticipated to expand at a CAGR of 5% from 2018 to 2026 to reach US$ 13,000 Mn by 2026. Increase in demand for modular cleanroom systems and advent of nanotechnology are likely to drive the global cleanroom consumables market during the forecast period. Major companies enter into distribution agreements to expand their footprint in the global market. Technological advancements and mergers & acquisitions are expected to propel the global cleanroom consumables market during the forecast period. For example, in February 2017, Ansell acquired Nitritex Limited, a U.K.-based company, which offers cleanroom and life science consumables. The company distributes its products in over 60 countries. Post the acquisition of Nitritex, Ansell also owned Nitritex’s flagship products BioClean and Omega. Based on product, the global cleanroom consumables market has been classified into cleanroom apparels, cleaning products, cleanroom stationery, wipers, gloves, and adhesive mats. The cleanroom apparels segment has been divided into coveralls, frocks, boot covers, shoe covers, bouffants, sleeves, pants, face masks, and hoods. The cleaning products segment has been categorized into cleanroom mops, buckets, wringers, and squeegees; validation swabs, and cleaning chemicals. The cleanroom stationery segment has been classified into papers, notebooks and adhesive pads, binders and clipboards, and labels. The wipers segment has been bifurcated into dry and wet. Based on application, the global market has been divided into electronics, pharmaceutical and biotechnology, aerospace and defense, academics and automotive, medical devices, and others. The academics and automotive segment is anticipated to expand at the highest CAGR during the forecast period. Cleanroom processing is employed in the automotive industry to manufacture and deliver safe and effective components due to high demand in automobile assembly lines. In terms of revenue, Asia Pacific dominated the global cleanroom consumables market in 2017, owing to growth of the food and beverage, food processing, pharmaceutical, biotechnology, and medical device industries. Rise in prevalence of contagious diseases and prominence of the domestic players are projected to drive the cleanroom consumables market in Asia Pacific in the near future. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3995 The report also provides profiles of leading players operating in the global cleanroom consumables market. Berkshire Corporation, KM, and KCWW are the major players operating in the market, offering products with proprietary technologies. Other players include Cantel Medical, Contec, Inc., DuPont, Micronclean, Ansell, Texwipe, Thermo Fisher Scientific, Inc., and Valutek. In June 2018, DuPont introduced Tychem gloves for chemical exposure protection. In the same year, Contec, Inc. introduced VertiKlean MAX range compact bucket system for cleaning and disinfecting in critical environments. DuPont entered into a partnership with Formosa Tafetta Company, a Taiwan-based new heated clothing company, in January 2018.  About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 18 2019 Hits: 5 Rating: 0.00 Votes: 0) Rate It

• Telehealth Market to Reach US$ 19.5 Bn by 2025 - Owing to the increase in geriatric population and rise in cardiovascular diseases, the global telehealth market is anticipated to witness a rapid growth rate. The competitive landscape of the market is highly fragmented regarding the number of players who provide services like hardware and software. Due to the increase in the number of chronic diseases like asthma, cancer and diabetes, there is the flow of demand for self-care solutions or devices. This is accompanied by the advancement in technology in terms of mobile health care and medical imaging which further boosts the telehealth market globally. Read Report Overview: https://www.transparencymarketresearch.com/telehealth-market.html There are a number of factors contributing to the growth of the telehealth market like the information and communication technology or ICT, advancement in mobile perforation, and connectivity. Since mobile access is pervasive all around the globe, it is easier for the telehealth market to prevail with time. There is rise in remote monitoring solution adoption by patients in rural areas may also add to the growth of the telehealth market globally. The telehealth market can also be expected to draw a large share of revenue owing to factors like effective image transfer, consistent evolution in communication and information technologies, and reporting and consultation. Adding to that, the scarce population of radiologists present around the world may also add to the increase in the overall growth of the telehealth market globally. The global telehealth market is anticipated to expand at a CAGR of 13.0% within the forecast period of 2017 to 2025. Previously the market was valued at US$ 6.0 bn as of the 2016 records. The rising number of chronic diseases and their concern is presumed to expand the growth of the global telehealth market during the forecast period. The global telehealth market is segmented on the basis of component, where the key classifications are services, software and hardware. The software segment is further classified into standalone software and integrated software. The services segment is further categorized into remote monitoring, store and forward, and real-time services. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41591 On the basis of application, the global telehealth market is classified as dermatology, psychiatry, remote intensive care unit or remote ICU, urgent care, cardiology and radiology. Cardiology, of all, seems to attract more revenue into the market and is anticipated to be the key application of telehealth. Increase in cardiovascular diseases and more heart diseases like strokes and attacks may account for almost about 19 percent share contribution to the telehealth market in the years to come. The global telehealth market is studied on the basis of key geographies Middle East and Africa, Latin America, Asia Pacific, Europe and North America. With regard to revenue, North America is seen to be having the dominance over the market all around the globe in the forecast period. This is due to the government initiatives taken in order to enlarge the adoption of telehealth services. So, North America is anticipated to continue its dominance over the telehealth market in the future years as well. The market is Asia Pacific is also presumed to expand at a notable CAGR rate during the forecast period. This due to the large number of patients who suffer from chronic diseases along with the aging population and also the heavy demand for improving the health infrastructure and cutting down health care expenditure, in developing nations of Australia, China, and India. Some of the key players in the global telehealth market are American Well, Honeywell International, Inc., Royal Philips, Aerotel Medical Systems Ltd., and Medtronic. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41591 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 18 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Advanced Wound Care Management Market to Reach US$ 14.05 Bn by 2026 - Advanced wound care management products are majorly used to treat more complex wounds. The products employ the principle of moisture therapy and fit around the shape of the wound. These are highly resistant to environmental inhibitors and foreign particles. For instance, hydrocolloid dressings contain hydrophilic substances, which absorb fluids, dirt, and bacteria, forming a protective gel mass. Maintenance of stable temperature around the wound, protection from infection, removal of dead tissues, assistance in oxygenation, and relieve in pain are major focus areas of advanced wound care products. The global advanced wound care management market was valued at US$ 8,531.0 Mn in 2017 and is anticipated to expand at a CAGR of 5.8 % from 2018 to 2026. The moist wound dressings segment dominates the global market. Rising prevalence of chronic wounds, technological advancements, increasing patient awareness and health care expenditure, and rising need for treatment of complex wounds are major factors driving the market. Considerable expansion of the active wound care segment is driven by significant expansion of the skin substitutes segment, which is due to the increasing need for effective treatment for disorders such as vascular ulcers, deep vein thrombosis, and skin disorders. The highly fragmented nature of the wound dressings market has encouraged market players to shift focus toward relatively niche segments such as advanced wound dressings. Venous ulcer, diabetic foot ulcers, and pressure ulcers are major types of chronic wounds, while surgical and burn cases are major type of acute wounds. Read Report Overview: https://www.transparencymarketresearch.com/advanced-wound-care-management-market.html The global advanced wound care management market has been segmented based on product, wound type, end-user, and region. In terms of product, the global market has been bifurcated into moist wound dressings, antimicrobial dressings, active wound care, and therapy devices. The moist wound dressings segment has been further sub-segmented into foam dressings, hydrocolloid dressings, hydrogel dressings, alginate dressings, collagen dressings, and others. The antimicrobial dressings segment has been further segregated into silver dressings and non-silver dressings. The active wound care segment has been further classified into artificial skin substitutes, autografts, and growth factors. The therapy devices segment has been further split into negative pressure wound therapy, oxygen and hyperbaric oxygen equipment, pressure relief devices, electromagnetic therapy devices, and others. Incidence of diabetic ulcers is rising rapidly due to increased incidence of both type I and maturity-onset diabetes in developed economies across the world. Diabetes prevalence in the U.S. and Europe is estimated to increase from 50 Mn in 2015 to 61 Mn by 2040. Based on wound type, the global advanced wound care management market has been segmented into acute wound and chronic wound. The acute wound segment has been further classified into surgical & traumatic wounds and burns. The chronic wound segment has been further bifurcated into infectious wounds & other ischemic wounds and ulcers. The ulcers segment has been further split into pressure ulcer, diabetic foot ulcer, arterial & venous ulcer, and other ulcers. According to a research paper published on NCBI (National Center for Biotechnology Information), in March 2017, the prevalence of diabetic foot ulcer, globally, (as a proportion of diabetic population) is 6.3%, with a significant prevalence in North America (13.0%). All these chronic wound cases are cumulatively boosting the advanced wound care market. In terms of end-user, the global advanced wound care management market has been divided into hospitals & clinics, ambulatory surgical centers, home health care, and others. Expansion of the hospitals & clinics segment can be attributed to the increase in prevalence of chronic wounds in inpatient settings, especially in ICUs. In terms of region, North America dominated the global advanced wound care management market in 2017 owing to a highly developed health care sector, increase in awareness among health care providers about wound care management, and continuous evolution of advanced wound care products. Europe is also an attractive market, in term of revenue. Rise in government initiatives and laws and increase in population drive the advanced wound care management market in the region. Increase in awareness about wound care and expansion of the health care sector in developing countries augment the market in Europe. Technological advancements and increase in adoption of advanced wound care products are expected to propel the advanced wound care management market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16139 Key players operating in the global advanced wound care management market include Smith & Nephew plc, Acelity L.P., Inc., Mölnlycke Health Care AB, ConvaTec Inc., B. Braun Melsungen AG, Coloplast A/S, 3M Healthcare, Integra LifeSciences Corporation, Cardinal Health, PAUL HARTMANN AG, BSN Medical, Hollister Incorporated, Organogenesis Inc., and Medline Industries, Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Micro Guide Catheters Market - Increasing Incidence of Vascular Diseases Stokes Demand - Players in the global micro guide catheters market are beefing up their product portfolio to serve unmet healthcare needs that helps them sustain competition as well. The staggering pool of patients with vascular diseases have led product manufacturers to boost their R&D capabilities and introduce novel products. This is boosting the micro guide catheters market. Read Report Overview: https://www.transparencymarketresearch.com/micro-guide-catheters-market.html Safety and efficacy features of micro guide catheters account for their extensive use for successful therapeutics and fast recovery from major invasive procedures. Micro guide catheters are thus preferred over diagnostic catheters to pass surgical instruments to reach the lesion site. However, factors such as limited insurance coverage to use micro guide catheters for therapeutics and high product recalls hampering revenue are holding back the micro guide catheters market’s growth. Considering a number of favorable factors, the global micro guide catheters market is likely to clock a healthy 7.6% CAGR between 2017 and 2024. The global market for micro guide catheters is segregated based on product type, indication, end user, and geography. The segments of the market based on product type are over-the-wire and flow-directed. Of the two, over-the-wire segment is anticipated to hold the larger 59.2% share of the overall market by 2024. The flow-directed segment is anticipated to be worth US$98.6 mn by 2024; the growth of this segment is attributed to decreased risk of intracranial hemorrhage and device flexibility due to factors such as lack of wire. Depending upon indication, cardiovascular, neurovascular, and others are the segments into which the micro guide catheters market is segmented. Out of these, cardiovascular is the most attractive segment that surpasses all in terms of growth rate due to its immense applications and advantages. Rising prevalence of cardiovascular diseases owing to several factors are expected to account for the dominance of cardiovascular segment through 2024. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11966 On the other hand, the neurovascular segment is likely to hold a significant 37.4% share of the market by 2024. Increasing number of brain aneurysms globally are expected to propel the neurovascular segment through the forecast period. By end user, the key segments into which the micro guide catheters market is divided are hospitals, ambulatory surgery centers, and specialty clinics. The hospitals segment, of them, is predicted to hold 44.2% share of the overall market by 2024. Hospitals is the most attractive segment as they are the facilities and technologies offered are highly appealing to patients. Hospitals are also mostly covered by healthcare insurance furthering the growth of this segment. Region-wise, the global micro guide catheters market is classified into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. Powered by the U.S., North America is the most attractive market for micro guide catheters. The U.S. spends on healthcare than any other country in the world. Early adoption of advanced medical devices and a state-of-the-art healthcare infrastructure is fuelling the North America micro guide catheters market. Key companies operating in the global market for micro guide catheters include Cardinal Health, Cook Medical, Asahi Intecc Co. Ltd., Penumbra Inc., Boston Scientific Corporation, Merit Medical Systems Inc., Medtronic plc, Terumo Europe NV, Koninklijke Philips N.V, and Integer Holdings Corporation. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11966 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Telemedicine Technologies and Services Market is Driven by the Penetration of Smartphones - Telemedicine technology offers convenience to the geriatric population to stay connected to their care providers, which reduces cost of travelling and long waiting time. Players are launching innovative and technologically advanced solutions to cater to the rise in demand for telemedicine solutions. The telemedicine technologies & services market has been segmented on the basis of component which includes hardware, software, and services. The global telemedicine technologies & services market was valued approximately US$ 21,000 Mn in 2016. It is anticipated to expand at a CAGR of more than 15% from 2017 to 2025 to reach approximately US$ 76,500 Mn by 2025. The services segment is likely to fuel the global telemedicine technologies & services market during the forecast period. Read Report Overview: https://www.transparencymarketresearch.com/telemedicine-technologies-market.html Rapid expansion of the global telemedicine technologies & services market is attributed to increase in incidence of chronic conditions and adoption of telemedicine solutions. Increase in incidences of Rise in demand for self-care devices/solutions such as mHealth and remote monitoring is expected to propel the market during the forecast period. According to the American Heart Association, cardiovascular diseases account for 17.3 million deaths globally each year, which is more than deaths caused due to cancer. Constant upgrade and innovation in products of telemedicine technologies is key strategy adopted by major players in the global telemedicine technologies and services market. New product launches in various segments have increased demand for telemedicine technologies and services in the market. Products such as Eve for Rad-97 Pulse COOximete (Masimo), MERIDIAN M110 (MindChild Medical), MRI Pacemaker (Abbott), and TactioRPM (Tactio Health Group) are emerging as benchmark in the telemedicine technologies and services market. Advancements in products, to add value and improve product offerings, has increased demand for telemedicine technologies and services in various diseases area. The telemedicine technologies & services market is in the development stage. Key market players such as, Koninklijke Philips N.V., Medtronic, and GE Healthcare have strong presence in the global telemedicine technologies and services market. Established players focus on increasing research & development activities to develop new, innovative, and technologically advanced products and attract more customers. Additionally, rise in telemedicine products create ample business opportunities for the development of cutting edge technologies that promote credibility and encourage product uptake. Therefore, rigorous investment in research & development activities for new product development and improvements in existing product portfolio are likely to help key players retain and increase their share in the global telemedicine technologies and services market. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=108 The telemedicine technologies & services market has been segmented based on component, specialty, services, and geography. In terms of component, the services segment is projected to dominate the market and is expected to continue to this trend during the forecast period, followed by hardware. Increase in applications of telemedicine technologies and services in various specialty fields, which include dermatology, gynecology, neurology, and cardiology is projected to drive the market. The neurology segment has been on the most encouraging segment for the use of microscopes as it has numerous specialty areas. Based on services, tele-consultation was a leading revenue generating segment in 2016 and is likely to continue dominating the market during the forecast period. The tele-care segment is likely to lose market share during the forecast period. The dermatology segment is expected to continue to dominate the market in 2025. Based on country, the U.S. accounted for the largest share of the global telemedicine technologies & services market in 2016. Increase in prevalence of chronic diseases, rise in government initiatives, growth in the number of installations of telemedicine solutions in various clinics and hospitals, and presence of a large number of suppliers and service providers are expected to drive the market in the U.S. The market in China is projected to gain market share in terms of revenue during the forecast period. Surge in venture capital funding for telemedicine solutions, increase in government initiatives for the adoption of telemedicine, growth of geriatric population, and rise in prevalence of chronic diseases such as diabetes and heart diseases are some anticipated to drive the telemedicine technologies & services market in China. Government initiatives and grants to increase adoption of telemedicine solution is expected to boost the market in the UK. In June 2016, the National Health Service of the U.K. announced that it was offering remote monitoring medical devices and apps to help millions of people manage chronic conditions. Key companies operating in the global telemedicine technologies & services market and profiled in the report include Medtronic, Koninklijke Philips N.V., Honeywell International, Inc., MindChild Medical, and Abbott. These players are adopting advanced techniques in the development of telemedicine products to expand their product offerings, expand geographical reach, increase customer base, and garner market share. For instance, in January 2017, MindChild Medical received the U.S. FDA approval for MERIDIAN M110, a noninvasive fetal heart monitor. In February 2017, Abbott MRI Pacemaker received the U.S. FDA approval for its novel advanced product MRI Pacemaker for both the Assurity MRI pacemaker and Tendril MRI pacing lead. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=108 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Respiratory Devices Market: Increase in Incidence of COPD and Sleep Apnea to Bolster the Market - Respiratory devices are medical equipment that assist patients with respiration in a critical care situation. Additionally, these devices are used to deliver medicines to treat several respiratory diseases. Furthermore, respiratory devices are used to diagnose respiratory problems. The global respiratory devices market was valued at US$ 17 Bn in 2017 and is projected to expand at a CAGR of 6.5% from 2018 to 2026 to reach US$ 31.0 Bn by 2026. Increase in incidence of COPD and sleep apnea, strategic alliances among key players, and rise in government expenditure are the major factors anticipated to propel the global respiratory devices market during the forecast period. However, high cost of respiratory devices and uncertain and ambiguous regulatory environment hamper the growth of the market. Read Report Overview: https://www.transparencymarketresearch.com/respiratory-devices-market.html Legislative amendments for medical devices and technology services by various governments across the world are likely to boost the global respiratory devices market during the forecast period. For instance, amendments in the Health Insurance Act 1973 of Australia for diagnostic imaging provided Medicare funding for diagnostic imaging services. This has had a positive impact since March 2008 in terms of better access to diagnostic imaging for patients across different categories. Additionally, new capital sensitivity provisions are likely to provide rebates on various diagnostic imaging services in the country. The American Asthma Foundation funds highly innovative research through a national grant program that recruits investigators from non-asthma fields. This could create lucrative opportunity for organizations willing to fund research in collaboration with universities or research organizations. In terms of product type, the global respiratory devices market has been segmented into therapeutic devices and diagnostic & monitoring devices. The therapeutic devices segment has been classified into drug delivery devices, mechanical ventilators, continuous positive airway pressure, resuscitators, humidifiers, airway clearance devices, oxygen concentrators, consumables & disposables, and others. The diagnostic and monitoring device segment has been categorized into pulse oximeters, capnographs, spirometers, polysomnographs, peak flow meters, gas analyzers, and others. Based on application, the market has been divided into chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, and pneumonia. The global respiratory devices market has been analyzed based on increasing cases of respiratory diseases, technology trend, expenditure on emerging technology, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. North America captured the largest share of the global respiratory devices market in 2017, owing to increase in the number of people suffering from respiratory diseases, rise in diagnosis and treatment, and presence of key players. Asia Pacific is projected to gain market share during the forecast period. The respiratory devices market in the region is anticipated to expand at the highest CAGR from 2018 to 2026, owing to rise in prevalence of respiratory diseases, increase in geriatric population, and government support for respiratory device manufacturers. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28073 Key companies operating in the global respiratory devices market and profiled in the report include ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company). These players are adopting organic and in-organic growth strategies to expand product offerings, strengthen geographical reach, increase customer base, and capture higher market share. Other players operating in this market are Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries, among others. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Neuroendocrine Carcinoma Market is Estimated to Represent US$ 2.5 Bn by 2027 -

  Recently, Future Market Insights has presented value analysis and insights on the various disease types, treatment types and end users associated with the neuroendocrine carcinoma market across key regions in the globe. It has also included an in-depth analysis on the various key players participating in the global neuroendocrine carcinoma market along with key developments taking place during the 2017-2027 timeline. Future Market Insights, in its recent publication titled “Neuroendocrine Carcinoma Market: Global Industry analysis (2012-2016) and Opportunity Assessment (2017-2027)” has covered a holistic angle of the global market for neuroendocrine carcinoma with a detailed market segmentation. This research report also unveils various opportunities, trends, drivers and restraints impacting the growth of the global neuroendocrine carcinoma market. Covering past and present market scenario, the global report also gives justice to the readers’ investment in procuring the research report by giving future market projections for a period of ten years.

  Global Neuroendocrine Carcinoma Market: Key Future Projections

  The global neuroendocrine carcinoma market is anticipated to witness high growth during the period of forecast to reach a valuation of about US$ 2.5 Bn by the end of the forecasted year from an estimate of around US$ 1.5 Mn in 2017. This market is projected to grow at a high 7.7% CAGR throughout the forecast period.

  Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1278

  Global Neuroendocrine Carcinoma Market: Key Influencing Aspects

  There are several aspects influencing the growth of the neuroendocrine carcinoma market. Few growth pushing aspects include rising awareness campaigns by governments for early detection and treatment, rising number of clinical trials in early phase development, exploring new generation sequencing technologies, increasing partnerships to strengthen product portfolios, identifying new solutions to fight cancer, increasing investments in research and development and quick regulatory approvals prompting use of new therapeutic solutions. Also, high cost associated with the treatment of neuroendocrine carcinoma, high cost of development leading to reduction in the number of players participating in this market and manufacturing challenges adversely impacting the product availability are limiting the growth of the global market for neuroendocrine carcinoma.

  Global Neuroendocrine Carcinoma Market: Segmental Acumen

  The global neuroendocrine carcinoma market is segmented on the basis of disease indication type treatment type, end user and by region.

  By region, North America region is expected to be highly attractive for the neuroendocrine carcinoma market. The North America neuroendocrine carcinoma market is anticipated to grow at a significant rate to register the highest estimate by the end of the forecasted year thus leading the global market. Also, Asia Pacific excluding Japan (APEJ) neuroendocrine carcinoma market is projected to grow at the highest pace to register a stellar CAGR of 8.5% throughout the forecast period

  By disease indication type, the gastric neuroendocrine tumours segment is the largest segment in terms of market value as well as growth rate. This segment is estimated at a high value of US$ 1.2 Bn by 2027 end followed by the lung neuroendocrine tumours segment, that stands at the second position in the global market

  By treatment type, the somatostatin analogs segment is expected to dominate the global market with a high market valuation of a bit more than US$ 1.5 Bn by the end of the forecasted year, growing at a noteworthy growth rate during 2017-2027 timeline

  By end user, hospitals segment is anticipated to the largest segment leading the global neuroendocrine carcinoma market with a high CAGR of 8.2% during the period of assessment, owing to high infrastructure investment towards adopting newer detection technologies. The clinics segment also reflects high potential in the years to come

  Request Customized Copy of Report @ https://www.futuremarketinsights.com/customization-available/rep-gb-1278 

  Global Neuroendocrine Carcinoma Market: Competitive Scenario

  The global neuroendocrine carcinoma market research report has included key players involved in the market. The SWOT analysis, product portfolio, developments, strategies, key financials and other key details of companies such as Pfizer Inc., Novartis AG, Chiasma Inc., Ipsen, Abbvie Inc., Valeant Pharmaceuticals International Inc., Jubilant Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Advanced Accelerator Applications, Mateon Therapeutics, Inc., Lexicon Pharmaceuticals, Inc., Isotopen Technologien München AGGlobal, Hutchison China MediTech Ltd., Amgen Inc., Celgene Corporation, Mallinckrodt plc., and Dauntless Pharmaceuticals, Inc., is included in this extensive research study.

  About Us

  Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

  FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

  Contact Us

  U.S. Office

  616 Corporate Way, Suite 2-9018,

  Valley Cottage, NY 10989,

  United States

  T: +1-347-918-3531

  F: +1-845-579-5705

  Email: sales@futuremarketinsights.com

  Web: https://www.futuremarketinsights.com/

  (Added: Thu Jan 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• 19th Annual Conference on Nephrology - The purpose of the conference is to share knowledge on recent advancements and innovations in Nephrology. The focus areas of the conference include Pediatric Nephrology, Chronic Kidney Diseases, Nephrology and Hypertension, Cardiovascular Diseases, Kidney Problems during Pre and Post Pregnancy, Diabetic Nephropathy, Kidney Anomalies, and many more. We welcome your participation in this conference. Should you, in addition, desire to present your research, unique technique or clinical experiences, kindly submit us your abstract. This can be done by sending to the attention of the scientific committee at https://nephrology.cmesociety.com/abstract-submission. The Abstracts of the conference will be published in the Conference Proceedings as well as Selected papers published in Journal of Nephrology & Renal Diseases. Please check out our conference website at https://nephrology.cmesociety.com We have limited Speaker Slots and opportunity to conduct Symposium/workshop at the conference. Grab the exciting waivers on Group Registration. Exhibit at our conference!! (Added: Thu Jan 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Global Paediatric Vaccine Market - According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion of healthcare expenditure in the recent times. The paediatric vaccine market is segmented according to indication, technology and vaccine type. According to the indication, the paediatric vaccine market is sub segmented into pneumococcal, DTP, rotavirus, influenza, meningococcal, hepatitis B, Hib, MMR and polio. According to technology the market is further segmented into live or attenuated, inactivated or killed, toxoid, conjugate, subunit and recombinant vaccines. By vaccine type, the global paediatric vaccine market is segmented into monovalent and multivalent vaccines. A slew of routine immunisation initiatives rolled out by the government and private agencies has broadened the market for the paediatric vaccines. A new wave of funds pumped into the market by different government and private players to cork the rise of the child deaths across the globe has also opened a new window of opportunity for the paediatric vaccine market. As per the report of WHO (World Health Organization), the global spending on immunisation soared from US$21.4 to US$26.9 per infant in 2014. The massive economic boom in some regions of the world is expediting the growth of the paediatric vaccine market. Segmentation analysis By indication, pneumococcal segment accounted for higher revenue share in global paediatric vaccines as compared to other product segments. The pneumococcal segment is expected to reach a value of US$ 31.58 Bn by 2026, reflecting a CAGR of 14.4% over the forecast period. The growth of pneumococcal segment is attributed to the increasing incidence of infectious diseases. In terms of revenue, Hib vaccine segment is the second most growing segment and is expected to reach a value of US$ 13.49 Bn by 2026, growing at a CAGR of 13.4%. Hepatitis B and meningococcal segment are expected to show double-digit CAGR growth in the forecast period contributing to the growth of global paediatric vaccine market. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1317 By technology, conjugate segment accounted for highest revenue share in global paediatric vaccine market as compared to live or attenuated segment. The conjugate segment is expected to reach a value of US$ 32.09 Bn by 2026, reflecting a CAGR of 14.8% over the forecast period. This is expected to be closely followed by the growth of pneumococcal and meningococcal vaccines in this segment By end user, institutional health centres account for higher demand for paediatric vaccine as compared to other end user segments such as hospital pharmacies and retail pharmacies. The strong growth in institutional health centres can be attributed to increasing government interventions in immunisation programs in order to improve vaccine coverage. Institutional health centres are expected to register highest CAGR of 13.8% over the forecast period. Regional analysis By region, North America is dominating the global paediatric vaccine market due to improved healthcare infrastructure in this region. The North America paediatric vaccine market is expected to be valued at US$ 20.15 Bn by 2026 growing at a CAGR for 11.0%. In addition to North America, demand for paediatric vaccines has been significantly growing in Western Europe and APEJ. APEJ is expected to grow at a CAGR for 14.9% over the forecast period and is expected to dominate the market by 2026 by generating revenue of US$ 22.69 Bn and revenues in Western Europe are anticipated to grow by 11.2%. Middle East and Africa is expected to grow at a CAGR of 12.6% and this growth is anticipated by growth government intervention for immunisation by carrying out national level immunisation campaigns and also disease specific immunisation campaigns. Request to View TOC @https://www.futuremarketinsights.com/askus/rep-gb-1317 Vendor insights Key players in the global paediatric vaccine market include Indian Immunologicals, GlaaxoSmithKline Plc., Pfizer Inc., Sanofi, Merck & Co. Inc., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., and Bharat Biotech. The growth of paediatric vaccine market is attributed to the development in the research by key players in the field, for instance, in February 2016, GSK submitted US regulatory submission for expanding the indication of FLuLaval Quadrivalent, influenza vaccine, for infants more than 6 months. These developments will boost the growth of the global paediatric vaccine market. (Added: Thu Jan 17 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Introduction of New Non-Invasive Ventilators has Revolutionized the Mechanical Ventilators Market - The global mechanical ventilators market has been expanding significantly over the last two decades, and the market has been characterized by technological innovation and increase in preference for portable and home-care ventilators. Rapid rise in the geriatric population, increase in incidence of chronic obstructive pulmonary disease (COPD), rise in incidence of respiratory emergencies, and technological innovation in respiratory care devices are major environmental factors that drive the mechanical ventilators market. However, tight budgetary constraints faced by ventilator manufacturers and healthcare service providers are key factors that, currently, restrain the market. Read Report Overview: https://www.transparencymarketresearch.com/mechanical-ventilators-market.html Technical advances, such as rapid innovation in the field of positive airway pressure (PAP) devices, portability, and improvement in battery life of transport and portable devices, are the primary influences in the mechanical ventilators market. Portability and easy movement of patients have expanded the mechanical ventilators market. Incorporation of portability in ventilators installed in critical care units has benefitted clinicians by bringing more flexibility in treatment, in accordance with changes in patient conditions and cost saving, by moving patients to low-cost care settings. The global mechanical ventilators market was valued at around US$ 1,621.5 Mn in 2017 and is anticipated to reach US$ 2,937.3 Mn by 2026, expanding at a CAGR of 6.9% from 2018 to 2026. Increasing prevalence of chronic diseases in the geriatric population, favorable reimbursement scenario, and increasing government initiatives toward geriatrics can be attributed to the expansion of the mechanical ventilators market during the forecast period. The global mechanical ventilators market has been segmented based on product type, interface, end-user, and region. In terms of product type, the mechanical ventilators market has been divided into critical care ventilators, neonatal ventilators, and transport and portable ventilators. In terms of interface, the market has been segregated into invasive ventilators and noninvasive ventilators. The critical care ventilators segment accounted for a prominent share of the market, in terms of revenue, in 2017. The segment is also expected to expand at a CAGR of 6.8% during the forecast period. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1397 In terms of region, North America accounts for a leading share of the global mechanical ventilators market, in terms of revenue, followed by Europe. High prevalence of respiratory diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare expenditure are boosting the market in the region. Moreover, strong research and development activities in the region promoting the development of new respiratory devices have contributed to the significant market share held by the region in the global mechanical ventilators. The contribution of revenue from the developed Western European economies, such as the U.K., Germany, France, and Italy, is responsible for the prominent share held by Europe in the global market. The amplifying base of the target patient population, i.e., geriatric people (over the age of 65 years) is anticipated to drive the mechanical ventilators market in Europe during the forecast period. The mechanical ventilators market in Asia Pacific is expected to expand at a significant pace due to developing healthcare infrastructure and increasing government support for people. Other regions, such as Middle East & Africa and Latin America, are expected to be lucrative markets for mechanical ventilators in the near future, due to the high rate of adoption of advanced medical devices coupled with the rapid expansion of the health care industry in these regions. Prominent players operating in the global mechanical ventilators market include Teleflex Incorporated, VYAIRE, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic plc, Koninklijke Philips N.V., Smiths Medical, ResMed Inc., Bunnell Inc., and Getinge AB. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1397 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Endoscope Reprocessing Device Market Worth US$ 2,171.5 Mn by 2027 -

  Global endoscope reprocessing device market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by growing geriatric population, increasing number of Endoscope surgeries and development of automated endoscope reprocessor and techniques. According to the new report, “Endoscope Reprocessing Device Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017–2027),” which has been published by Future Market Insights for the projected period of 10-years, i.e. during 2017 to 2027, the endoscope reprocessing device market in MEA is expected to record comparatively less growth due to low awareness about infection control and less availability of reprocessor. The global endoscope reprocessing device market to grow from US$ 949.9 Mn in 2016 to US$ 2,171.5 Mn by 2027 end. This represents CAGR of 7.9% over the forecast period of 2017–2027

  Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2058 

  Global Endoscope Reprocessing Device Market: Restraints

  • Reported Adverse Events From Failure of Endoscope Reprocessing
  • Excise duty imposed on medical device manufacturers would reduce profit margin
  • High Cost of Technology Hampering the Growth of Endoscope Reprocessing Device Market
  • Inadequate Reimbursement Policies Restrain the Market Growth
  • Delayed Reprocessing and Lack of Clarity of Instruction
  • Stringent Rules and Regulations
  • Dearth of Trained Endoscopy Specialists and Professionals
  • Poor Health Care System Hampering the Market growth
  • Low Awareness of Endoscope Reprocessing in Developing Countries  are Hampering the  Market Growth
  • Lack of Proper Healthcare Infrastructure In Emerging Markets
  • Increase in Pricing Competition for Endoscope Reprocessing Device

  Global Endoscope Reprocessing Device Market: Forecast by Product

  Global endoscope reprocessing device market is categorized into automated endoscope reprocessor, washer disinfector, sterilizer, ultrasonic washer and drying and storage Cabinet. The study covers revenue generated by product type which includes, above mentioned product type. However, the study does not consider the revenue from which are not mentioned in the report. This report analyses installed base and new sale devices. Sterilizer and automated endoscope reprocessor segment dominated the global endoscope reprocessing device market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Sterilizer segment is expected to be the most lucrative among all product type, with attractiveness index of 1.6.

  Global Endoscope Reprocessing Device Market: Forecast by End User

  Endoscope reprocessing devices based on end user, the total installed base and new sale of endoscope reprocessing devices obtain from the three end user such as hospital, ambulatory surgical centre and specialty clinics. The study covers revenue generated by hospitals, ambulatory surgical centre and specialty clinics which includes, installed devices and new sale of devices. However, the study does not consider the revenue from which are not mentioned in the report.

  Request Customized Copy of Report @ https://www.futuremarketinsights.com/customization-available/rep-gb-2058 

  Global Endoscope Reprocessing Device Market: Regional Analysis

  As many as seven regions have been covered in this report, such as North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan, and MEA. If CAGR is considered, Latin America, Eastern Europe and APEJ have highest CAGRs throughout the forecasted period among all other regions. However, in terms of revenue North America and APEJ dominated the global endoscope reprocessing device market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. North America and APEJis expected to be the most lucrative among all regions, with attractiveness index of 2.1 and 1.7 respectively.

  Global Endoscope Reprocessing Device Market: Competitive Landscape

  Medivators Inc., Olympus Corp., STERIS Plc., Getinge Group, Hoya Group, Laboratoires Anios, Custom Ultrasonics, Inc., SciCan Ltd (Sanavis Group), Shinva Medical Instrument co., Ltd., ARC Healthcare Solutions Inc., Antonio Matachana SA, Choyang Medical Industry Ltd., DGM Pharma-Apparate Handel Ag, MMM Medical Equipment UK LTD, Medonica Co. Ltd., Belimed AG (Metall Zug), Steelco S.P.A, and Advanced Sterilization Products Services Inc., are some of the key players operating in the global market for endoscope reprocessing device market.

  About Us

  Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

  FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

  Contact Us

  U.S. Office

  616 Corporate Way, Suite 2-9018,

  Valley Cottage, NY 10989,

  United States

  T: +1-347-918-3531

  F: +1-845-579-5705

  Email: sales@futuremarketinsights.com

  Web: https://www.futuremarketinsights.com/

  (Added: Thu Jan 17 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Safety Syringes Market Research Available in New Report - The injectable route of administration is quite common for faster delivery of drugs and medication. It is used for various purposes such as diagnosis, prevention, and treatment of diseases. These purposes require safe injectable route of administration to patients. Injectable route of administration should also be safe for healthcare providers to deliver. Safe injection is the method which should be risk free, harmless to patient and provider and should not cause any infection. Safety syringes protect health care providers from needlestick injuries. These are equipped with an inbuilt safety mechanism and needles that are detachable or permanently attached. Various countries have introduced legislation for compulsory usage of safety syringes from prevention of needle stick injuries. This initiative has led to more common use for safety syringes. Read Report Overview: https://www.transparencymarketresearch.com/safety-syringes-market.html Rise in prevalence of chronic diseases such as diabetes and increase in incidence of needlestick injuries are the major factors boosting the growth of the global safety syringes market. According to the WHO, 3 million accidental needle-stick injuries were reported in 2003, with 37% new hepatitis B cases in health care workers, 39% of new hepatitis C cases, and around 5.5% of new HIV cases. Moreover, around 422 million people had diabetes across the world in 2016. Increase in health care spending, rise in prevalence of blood borne diseases, and surge in awareness about the benefits of safety syringes drive the global safety syringes market. Preference for other delivery methods in developing countries and lack of awareness about needlestick injuries are the factors restraining the global safety syringes market. The global safety syringes market can be segmented based on product type, therapy, end-user, and region. In terms of product type, the global market can be bifurcated into retractable safety syringes and non-retractable safety syringes. The retractable safety syringes segment dominated the global market in 2017 due to ease of use, reduced time, and improved safety. The retractable safety syringes segment can be classified into manual retractable syringes and automatic retractable syringes. The manual retractable safety syringes sub-segment held major share of the retractable safety syringes segment in 2017. The sub-segment is anticipated to continue to dominate the segment during the forecast period owing to lower cost than automatic retractable syringes. Based on therapy, the global safety syringes market can be categorized into insulin, glucagon-like peptide-1 (GLP-1), tuberculosis, growth hormones, and others. Insulin and tuberculosis are lucrative segments due to high incidence of diabetes and tuberculosis. In terms of end-user, the global market can be divided into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment dominated the global market in 2017 owing to developed infrastructure and technologically advanced therapeutic procedures. In terms of region, the global safety syringes market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 and the trend is expected to continue during the forecast period. Well-established health care infrastructure, high number of needlestick injuries, and rise in awareness about prevention of diseases are the major factors driving the safety syringes market in North America. The market in Asia Pacific is projected to expand at the highest CAGR in the next few years due to increase in population, rise in prevalence of diabetes, and surge in awareness about sharp injuries. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54696 The global safety syringes market is highly competitive and fragmented due to presence of major companies. Key players operating in the global safety syringes market include Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, NIPRO Medical Corporation, Baxter Healthcare Corporation, Retractable Technologies, Inc., Smiths Medical, Medtronic plc, JMI Syringes & Medical Devices Limited, and Terumo Medical Corporation. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Arginine Market by Pharmaceuticals & Healthcare Analysis 2018 to 2026 - Arginine, which is also known as L-arginine, is an essential amino acid for humans. Arginine is present in all protein-containing foods such as grains, beans, nuts, meat, dairy products, and eggs, and it is also synthesized in the body from glutamine via citrulline amino acid. Arginine plays an important role in cell division, wound healing, removal of ammonia from the body, boosting immune function, and in the release of hormones. Arginine Market: Drivers For instance, an article published in PLOS One journal in May 2015 suggested that arginine might alter multi-species oral biofilm development and may also break down dental plaque, which could help millions of people in preventing dental decay and gum diseases. Furthermore, new product development is expected to fuel growth of the arginine market. For instance, in October 2018, Nutrition 21, LLC announced that its clinically substantiated ingredient, Nitrosigine, is now included in Elite Gold NX6 product. Elite Gold NX6 is a polymer of arginine silicate, which is stabilized by inositol. Therefore, the development of Elite Gold NX6 with nitrosigine ingredient will help in boosting nitric oxide levels, which is found to be a key factor in generating greater blood flow and vasodilation in working muscles. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2238 Arginine Market: Restraint Product recalls for arginine drug packaging is expected to hamper growth of the arginine market. For instance, in November 2017, Therapeutics Goods Administration (TGA) of Australia recalled Apotex Inc.’s Apo-Perindopril Arginine 2.5 mg, 5 mg, and 10 mg tablet batches from the market due to contamination of tablet bottles with dark particles of silica. This contamination was classified as a quality defect. Apo-Perindopril Arginine is indicated for high blood pressure, heart failure or coronary artery disease. Moreover, United Pharmacy recalled two lots of a compounded injectable glutamine/arginine/carnitine product, GAC-12 and GAC-13, in November 2017. Arginine Market: Regional Analysis On the basis of region, the global arginine market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to account for the largest share in the arginine market due to new product launches in the U.S. For instance, Pfanstiehl, Inc., a U.S.-based company, in September 2018, launched a new high-purity, low-endotoxin, and low-metal, L-Arginine, which meets the U.S. Pharmacopoeia (USP), European Pharmacopoeia (EP), Japan Pharmacopoeia (JP), and Chinese Pharmacopoeia (ChP) standards. This is the first amino acid that Pfanstiehl, Inc. launched and manufactured in the U.S. under strict current good manufacturing practice (cGMP) and International Conference on Harmonization (ICH) Q7 compliant conditions. Asia Pacific region is also expected to witness significant growth in the arginine market, owing to expansions of key players for the production of arginine formulations. For instance, in April 2018, CJ CheilJedang, a China-based firm, announced to expand its L-Arginine and L-Citrulline production at its Jombang plant in Indonesia, which will be effective from 2019. By this expansion, the company also plans to manufacture its product, L-Citrulline (precursor of Arginine in body), simultaneously in both China and Indonesia. Click To Reading More On Arginine Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Thu Jan 17 2019 Hits: 5 Rating: 0.00 Votes: 0) Rate It

• Glucose Biosensors Market is expected to reach 3520 million US$ by the end of 2025 - This report studies the global Glucose Biosensors market status and forecast, categorizes the global Glucose Biosensors market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The biosensor is a sensing device, which consists of a combination of a specific biological element and a transducer. Biosensors are defined as analytical devices that convert a biological response into electrical signal and assist in measuring a wide spectrum of analytes including organic compounds, gases, bacteria and others. At present, in developed countries, the glucose biosensors industry is generally at a more advanced level. The world's large enterprises are mainly concentrated in USA and Europe. Meanwhile, foreign companies have more advanced equipment, strong R & D capability, and leading technical level. However, foreign companies’ manufacturing cost is relatively higher, compared with Chinese companies. With the development of Chinese glucose biosensors production technology, their share in the international market is increasing, and competitiveness in the international market gradually increases. Although glucose biosensors brings a lot of opportunities, the study group recommends the new entrants just having money but without technical advantage and upstream and downstream support do not to enter into this field. Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/172586/global-glucose-biosensors-market The global Glucose Biosensors market is valued at 3120 million US$ in 2017 and will reach 3520 million US$ by the end of 2025, growing at a CAGR of 1.5% during 2018-2025. The major manufacturers covered in this report Roche LifeScan Bayer Abbott ARKRAY Omron I-SENS B. Braun Dexcom AgaMatrix SANNUO YICHENG Yuwell Andon Health Yingke Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering North America Europe China Japan Southeast Asia India Benefits of Purchasing QY Research Report Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report Customer’s Satisfaction: Our expert team will assist with all your research needs and customize the report Inimitable Expertise: Analysts will provide deep insights about the reports Assured Quality: We focus on the quality and accuracy of the report Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/172586/global-glucose-biosensors-market About Us: QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry. Contact US QY Research, INC. 17890 Castleton, Suite 218, Los Angeles, CA - 91748 USA: +1 6262 952 442 China: +86 1082 945 717 Japan: +81 9038 009 273 India: +91 9766 478 224 (Added: Thu Jan 17 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Healthcare Payer Services Market Forecast to 2025 Made Available by Top Research Firm - Healthcare payer services are services that are outsourced by healthcare insurance payers and providers. The changing dynamics of the healthcare sector are compelling payers to rethink business models and processes to deal with the competition in the market while providing better quality patient care by streamlining the process, reducing costs, and improving customer communication. These are the major concerns for healthcare payers and to overcome the obstacles, healthcare payers are currently outsourcing this service to healthcare payer service providers. Read Report Overview: https://www.transparencymarketresearch.com/healthcare-payer-services-market.html The healthcare payer services market is expected to grow due to increasing number of healthcare payer service providers and increasing pressure of cost cutting. The cost of outsourcing healthcare payer service is less compered to in-house payer services. With increasing technological advancement and increasing adoption of analytics in healthcare, and increasing number of people opting for healthcare insurance, the base of customers is growing day by day. This is likely to propel the growth of the market during the forecast period. However, factors such as increasing incidence of cyber theft, i.e., loss of confidential data, and hidden cost associated with outsourcing is expected to hamper the growth of the healthcare payer service market during the forecast period. The healthcare payer services market has been segmented by service type, application, end-user, and geography. In terms of service type, the market has been categorized into business process outsourcing (BPO), information technology outsourcing (ITO), and knowledge process outsourcing (KPO). Business process outsourcing is expected to account for larger market share due to increasing cost cutting pressure and rising implementation of ICD-10 codes. Based on application, the healthcare payer services market has been segmented into claims management, HR services, billing and accounts management, analytics and fraud management and others. Claims management is expected to account for larger market share due to increasing number of people enrolling for health insurance. Claims calculation is very time consuming and tedious. Outsourcing of claims management to healthcare payers service providers reduces cost and saves time for insurance companies. Based on end users, the healthcare payer services market has been segmented into private payers and public payers. Geographically, the healthcare payer services market has been categorized into five regions. These include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for larger market share due to extensive technological advancements in the region. Rising implementation of ICD-10 codes in the U.S. and increasing number of people opting for health insurance, would boost market growth. Moreover, presence of developed IT and healthcare infrastructure, and increasing number of healthcare payer services providers is expected to propel the growth of the healthcare payer services market in the region. Europe is expected to be the second largest market in healthcare payer services owing to enhanced digitization of healthcare processes and implementation of technologically advanced systems in the region. The major factor that would drive the market in Asia Pacific include the acceptance and demand for high end medical infrastructure, and availability of services at lower cost compared to North America and Europe. China, Japan, and India are the most developing countries in the region and hence would fuel the market growth for healthcare payer services. Latin American countries such as Brazil and Mexico have significant potential for growth due to evolving medical structure and high disposable income. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30431 The major players operating in the healthcare payer services market include UnitedHealth Group, Inc., Cognizant Technology Solutions, IBM Corporation, Genpact, Accenture PLC, Xerox Corporation, Hewlett-Packard, Aetna Inc., EXL Service Holdings, Inc. and Wipro Limited. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 17 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... [>>]